HDAX Therapeutics and Noa Therapeutics' CEOs selected among the 2024 Termeer Fellows

Ontario Industry UpdatesOBIO News
Written By Arsheen Kaur

The Termeer Fellowship Program recently announced the class of 2024 Termeer Fellows – a group of fifteen visionary leaders who are passionate about transforming patient care through innovations. The fellows will receive leadership programming, mentorship, and access to a network of industry leaders.

 Congratulations to the selected leaders! Shout-out to Nabanita Nawar, CEO and Co-founder, HDAX Therapeutics and Carla Spina, CEO and Co-founder, Noa Therapeutics!

HDAX Therapeutics and Noa Therapeutics are OBIO® members and alumni of our BDSP™ and WiHI programs.

Arsheen Kaur
Previous

Rocket Doctor selected for the inaugural cohort of the Google for Startups Accelerator
Next

Hyivy Health featured in the Globe and Mail